Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2

Status

Completed 16Terminated 4Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Hyperandrogenism 1

Interventions

Cyclophosphamide 222pembrolizumab 201Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 155Docetaxel 140Bevacizumab 138Rituximab 137Radiotherapy 137Nivolumab 126Dexamethasone 126Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 63Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Has results × Flutamide × Clear all
NCT00003645 2020-04-28

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

M.D. Anderson Cancer Center

Phase 3 Terminated
64 enrolled 12 charts
Genitourinary

Prostatic Neoplasms

NCT01428193 2018-06-04

Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone

University of Virginia

Phase NA Terminated
4 enrolled 5 charts

Polycystic Ovary Syndrome, Hyperandrogenism

NCT00729560 2014-09-08

PCOS

Virginia Commonwealth University

Phase NA Terminated
8 enrolled 4 charts

Polycystic Ovary Syndrome

NCT00388804 2012-08-08

External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer

M.D. Anderson Cancer Center

Phase 3 Terminated
39 enrolled 3 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡